- Clinical trials going digital.
- JAMA return-to-play guidance.
- Would a COVID-19 vaccine produce larger health or economic benefits?
- Pros and cons of telemedicine.
- Are we there yet? A review of 4 value-based care programs.
from Healthcare Economist https://ift.tt/31X0NJ3
via IFTTT
No comments:
Post a Comment